Indeed, recent updated guidance published by the European Association for the Study of Diabetes (EASD), followed in Portugal, indicated GLP-1 receptor agonists or SGLT-2 inhibitors as second-line therapies (following metformin) in patients with type 2 diabetes with high risk of atherosclerotic cardiovascular disease, heart failure, or chronic kidney disease [7, 8]
For more detail on how all of the major forms compare, see our full breakdown of different types of magnesium
Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminophen-induced acute liver injury
identifying individuals who may be prone to complications despite seemingly managed glucose levels
I have had many customers come to me with batteries that died because they charged it up, intending to use it, but life got in the way and they never remembered to put it back to storage voltage
Sex determination in the Caenorhabditis elegans germline